These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38383521)

  • 21. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
    Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
    J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The initial resuscitation of septic shock.
    Cinel I; Kasapoglu US; Gul F; Dellinger RP
    J Crit Care; 2020 Jun; 57():108-117. PubMed ID: 32135409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternatives to norepinephrine in septic shock: Which agents and when?
    Jozwiak M
    J Intensive Med; 2022 Oct; 2(4):223-232. PubMed ID: 36788938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
    Allen JM; Gilbert BW
    Clin Ther; 2019 Dec; 41(12):2594-2610. PubMed ID: 31668356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
    Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED
    J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274
    [No Abstract]   [Full Text] [Related]  

  • 28. The Role of Angiotensin II in Poisoning-Induced Shock-a Review.
    Chen A; Wong A
    J Med Toxicol; 2022 Apr; 18(2):145-154. PubMed ID: 35258848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of angiotensin II in treatment of refractory distributive shock.
    Rodriguez R; Fernandez EM
    Am J Health Syst Pharm; 2019 Jan; 76(2):101-107. PubMed ID: 31361800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressors to treat refractory septic shock.
    Meresse Z; Medam S; Mathieu C; Duclos G; Vincent JL; Leone M
    Minerva Anestesiol; 2020 May; 86(5):537-545. PubMed ID: 31994366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A plea for personalization of the hemodynamic management of septic shock.
    De Backer D; Cecconi M; Chew MS; Hajjar L; Monnet X; Ospina-Tascón GA; Ostermann M; Pinsky MR; Vincent JL
    Crit Care; 2022 Dec; 26(1):372. PubMed ID: 36457089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock.
    Khalique SC; Ferguson N
    Cardiol Rev; 2019; 27(3):167-169. PubMed ID: 30601161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations.
    Der-Nigoghossian C; Hammond DA; Ammar MA
    Ann Pharmacother; 2020 Jul; 54(7):706-714. PubMed ID: 31958982
    [No Abstract]   [Full Text] [Related]  

  • 37. Roles of angiotensin II as vasopressor in vasodilatory shock.
    Lumlertgul N; Ostermann M
    Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
    Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
    J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes.
    Udeh CI; Diaz-Gómez JL; Anthony D; Satyapriya A; Perez-Protto S; Hata JS
    Curr Pharm Des; 2012; 18(38):6308-13. PubMed ID: 22762470
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.